The Group Managing Director/Chief Executive Officer (CEO) of Emzor Pharmaceuticals Industries Limited, Dr. Stella Okoli, has expressed worry over the problem of drug abuse in the country and its effects on youths and children.
Speaking on Sunday during a press conference on the reopening of the company’s liquid production line earlier shut by the National Agency for Food and Drug Administration and Control, (NAFDAC), Okoli said tackling the problem of drug abuse required a multi-sectoral approach.
She said: “Emzor will seek to make relevant and impactful contributions to the multi-agency discussions on the way forward that are sure to follow in the days and months ahead.
“From the limited depiction of rehabilitation efforts represented in the BBC programme, there is room for much support and improvement in the treatment and rehabilitation of persons affected by addiction.
“As an organisation we will continue to contribute to this vital aspect of managing the problem and securing the National treasure that is our youth.”
Expressing delight over the reopening of her factory, Okoli said: “We are happy to announce that after carrying out all necessary due diligence, NAFDAC has now reopened the factory.”
NAFDAC had on Saturday lifted the shutdown order on Emzor Pharmaceuticals’ factory and two other comapanies; Peace Standard Pharmaceutical Limited and Bioraj Pharmaceutical Limited in Ilorin, Kwara State which were shutdown over codeine syrup crisis.